Intractible cutaneous non-Hodgkin's lymphoma of the lower limb. Complete remission after sequential regional isolated hyperthermic perfusion and perfusion with 1-phenylalanine-mustard (melphalan, L-pam)
- 15 July 1989
- Vol. 64 (2) , 392-395
- https://doi.org/10.1002/1097-0142(19890715)64:2<392::aid-cncr2820640209>3.0.co;2-l
Abstract
A 61-year-old man with an intractible and progressively disabling cutaneous non-Hodgkin's lymphoma (NHL) in the lower limb was treated with sequential regional isolated perfusion at 10-day intervals. The first perfusion was hyperthermic (40.2–43.1°C tumor-temperature); the second was at controlled normothermia with high-dose l-phenylalanine mustard (melphalan, L-Pam; 11 mg/l perfused tissue). This treatment resulted in a complete remission in the perfused area of significant duration and has prevented amputation.This publication has 7 references indexed in Scilit:
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- PHARMACOKINETICS OF MELPHALAN IN ISOLATED PERFUSION OF THE LIMBS1986
- Hyperthermia in the treatment of cancer: Perspectives on its promise and its problemsCancer, 1984
- Thermal dose determination in cancer therapyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- The relationship between heating time and temperature: its relevance to clinical hyperthermiaRadiotherapy and Oncology, 1983
- IntroductionPublished by Springer Nature ,1983
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982